Progrip Versus ProFlor: Two Fixation Free Devices for Laparoscopic Inguinal Hernia Repair
Launched by UNIVERSITY OF PALERMO · Aug 13, 2024
Trial Information
Current as of July 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • bilateral inguinal hernia
- Exclusion Criteria:
- • Recurrent inguinal hernia
- • Incarcerated inguinal hernia
- • Hernia not in the inguinal area
- • Signs of obvious local or systemic infection
- • ASA score \> 4
- • Presenting with unstable angina or NYHA class of IV
- • Pregnant
- • Active drug user
- • Immunosuppression, chemotherapy
- • Chronic renal insufficiency
- • Abdominal ascites
- • Infection in area of the surgical field
- • BMI \>34
About University Of Palermo
The University of Palermo, a distinguished institution located in Italy, is dedicated to advancing medical research and education through innovative clinical trials. Renowned for its commitment to scientific excellence, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct research that addresses critical healthcare challenges. By fostering collaborations with leading researchers and healthcare professionals, the University of Palermo aims to translate scientific findings into effective therapies, ultimately contributing to improved patient outcomes and public health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palermo, , Italy
Patients applied
Trial Officials
Giuseppe Di Buono
Principal Investigator
University of Palermo
Antoninoq Agrusa
Study Director
University of Palermo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported